-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Mbl94yk8PVRvLC5cfaNz5jmngR2bR+ML6UATiACtmbf2fDqelL4kjE8a0sutFtvB JlpLz2RlTWUGYZui2z91Iw== 0001181431-05-031075.txt : 20050611 0001181431-05-031075.hdr.sgml : 20050611 20050526172440 ACCESSION NUMBER: 0001181431-05-031075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050525 FILED AS OF DATE: 20050526 DATE AS OF CHANGE: 20050526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STONE DAVID K CENTRAL INDEX KEY: 0001248571 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 05860963 BUSINESS ADDRESS: STREET 1: 24 LIBERTY ST CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 9782638776 4 1 rrd80552.xml X0202 4 2005-05-25 0 0000356830 OSCIENT PHARMACEUTICALS CORP OSCI 0001248571 STONE DAVID K 1000 WINTER STREET SUITE 2200 WALTHAM MA 02451 1 0 0 0 Stock Options (right to buy) 1.78 2005-05-25 4 A 0 12000 1.78 A 2015-05-24 Common stock 12000 139665 D Re-election to Board - vest annually in equal installments over 3 years from date of grant Robert E. Farrell Jr Corp Controller/Treasurer Power of Attorney 2005-05-26 -----END PRIVACY-ENHANCED MESSAGE-----